JFL Life Sciences IPO Review
JFL Life Sciences IPO Overview
JFL Life Sciences Limited, founded in 2010, is a pharmaceuticals manufacturer Products. The company’s product range includes dry powder injections (B-Lactam), pill and capsules (B-Lactam) conventional oral dosage form, tablet and capsules (general) oral solid dosage form, and oral rehydration solutions (ORS).
The company’s sales approach is to offer items in bulk to pharmaceutical marketers and merchants, who then provide a route for sales to clients. JFL Life Sciences Limited has a market position in PAN India, and its goods are sold in ten developed and developing nations across the world.
JFL Life Sciences Limited primarily sells to Middle Eastern, African and CIS nations via merchant exporters. The firm is registered with the Ministries of Health of Kenya, Nigeria, Yemen, Cambodia, and Myanmar to manufacture a certain product. A few of our items are also listed with merchants in Ukraine, Uzbekistan, and Kazakhstan (CIS nations).
JFL Life Sciences IPO Details
JFL Life Sciences IPO Date | Aug 25, 2022 to Aug 30, 2022 |
JFL Life Sciences IPO Face Value | ₹10 per share |
JFL Life Sciences IPO Price | ₹61 per share |
JFL Life Sciences IPO Lot Size | 2000 Shares |
Issue Size | 2,978,000 shares of ₹10 (aggregating up to ₹18.17 Cr) |
Fresh Issue | 2,978,000 shares of ₹10 (aggregating up to ₹18.17 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | NSE SME |
Retail Shares Offered | 50% of the net offer |
NII (HNI) Shares Offered | 50% of the net offer |
Company Promoters | Smiral Ashwinkumar Patel and Tejal Smiral Patel are the company promoters. |
JFL Life Sciences IPO Financial Performance
Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus |
31-Aug-19 | 1614.96 | 3177.96 | 30.25 | 501.49 | 459.2 |
31-Mar-20 | 2432.59 | 3020.41 | 36.04 | 537.53 | 495.24 |
31-Mar-21 | 2900.69 | 3286.89 | 54.21 | 687.25 | 637.55 |
28-Feb-22 | 3662.86 | 2563.06 | 253.28 | 1096.52 | 294.48 |
Amount in ₹ Lakhs | |||||
JFL Life Sciences IPO Key Ratios
|
| FY2020 | FY2021 | 11M FY2022 |
EPS | 0.59 | 0.66 | 0.89 | 3.77 |
PE ratio | – | – | 68.54 | 16.18 |
RONW (%) | 6.03 | 6.70 | 7.89 | 25.20 |
EBITDA (%) | 4.16 | 6.28 | 6.86 | 20.63 |
NAV | – | – | 13.67 | 138.29 |
Listing Performance of JFL Life Sciences IPO
Listed On : NSE SME
Issue Price : ₹61 per share
Listing Day Close :
Listing Day Gain :
JFL Life Sciences IPO ISIN Code
NSE : NA
ISIN CODE :INE0LA901015
BSE : NA
JFL Life Sciences IPO Allotment Status
JFL Life Sciences IPO Important Dates
JFL Life Sciences IPO Opening Date | Aug 25, 2022 |
JFL Life Sciences IPO Closing Date | Aug 30, 2022 |
Basis of Allotment | Sep 5, 2022 |
Initiation of Refunds | Sep 6, 2022 |
Credit of Shares to Demat | Sep 7, 2022 |
JFL Life Sciences IPO Listing Date | Sep 8, 2022 |
JFL Life Sciences IPO Contact Details
309, Satyam Mall,
Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir
Settelite, Ahmedabad 380015
Phone: 937729 5575
Email: cs@jfllifesciences.com
Website: http://www.jfllifesciences.com/
JFL Life Sciences IPO Registrar Contact Details
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: jfl.ipo@kfintech.com
Website: https://karisma.kfintech.com/
JFL Life Sciences IPO FAQ's
The JFL Life Sciences IPO is a NSE SME IPO of ₹16 per share with a face value of 10 per equity share.
The issue size is priced at 2,978,000 shares of ₹10 (aggregating up to ₹18.17 Cr).
The fresh issue size priced at 2,978,000 shares of ₹10 (aggregating up to ₹18.17 Cr).
The initial public offering (IPO) begins on Aug 25, 2022 and ends on Aug 30, 2022.
The registrar for the IPO is Link Intime India Private Ltd. The shares are proposed for listing on the BSE and SME.
The JFL Life Sciences IPO opens on Aug 25, 2022 and closes on Aug 30, 2022.
JFL Life Sciences IPO Market lot size is 2000 Shares and the minimum order quantity is 2000 Shares.
The finalisation of Basis of Allotment for JFL Life Sciences IPO will be done on Sep 5, 2022. and the allotted shares will be credited to your demat account by Sep 7, 2022. Check the JFL Life Sciences IPO status.
The JFL Life Sciences IPO listing date is on Sep 8, 2022.
JFL Life Sciences IPO applications can be submitted online using either UPI or ASBA as a payment method. The ASBA IPO application is available in your bank’s net banking. Brokers who do not provide banking services provide UPI IPO applications. Learn more about online IPO applications from Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.
JFL Life Sciences IPO Comments
Share this Content
Main Board IPO
SME IPO 2021
Upcoming IPO